Shuo Chen

Title: Innovations of Shuo Chen in Pharmaceutical Development

Introduction

Shuo Chen is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for capsid protein assembly. With a total of 3 patents, his work focuses on addressing diseases caused by hepatitis B virus infection.

Latest Patents

Shuo Chen's latest patents include innovative compounds that serve as capsid protein assembly inhibitors. One of his notable inventions is a pharmaceutical composition that includes a compound of formula I or II, which can be a stereoisomer, a tautomer, a geometrical isomer, a solvate, an active metabolite, a hydrate, a prodrug, or a pharmaceutically acceptable salt. This composition is designed for medical uses in treating diseases that benefit from the capsid protein assembly inhibitor, particularly those caused by hepatitis B virus infection. Another patent focuses on a similar N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, emphasizing its pharmaceutical composition and medical applications.

Career Highlights

Shuo Chen is currently employed at Chia Tai Tianqing Pharmaceutical Group Co., Ltd. His work at this esteemed company has allowed him to advance his research and contribute to the development of effective pharmaceutical solutions. His innovative approach and dedication to his field have positioned him as a key figure in pharmaceutical research.

Collaborations

Shuo Chen collaborates with esteemed colleagues such as Yinsheng Zhang and Wangwei Ao. Their combined expertise enhances the research and development efforts within their projects.

Conclusion

Shuo Chen's contributions to pharmaceutical innovation, particularly in the area of hepatitis B treatment, highlight his role as a significant inventor in the field. His patents reflect a commitment to advancing medical science and improving patient outcomes.